Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Zoetis Inc.

Capitalization 48.74B 42.28B 38.23B 36.5B 66.39B 4,500B 68.72B 455B 181B 2,150B 183B 179B 7,761B P/E ratio 2026 *
17.4x
P/E ratio 2027 * 16.2x
Enterprise value 53.92B 46.77B 42.29B 40.38B 73.45B 4,978B 76.02B 503B 200B 2,379B 202B 198B 8,585B EV / Sales 2026 *
5.44x
EV / Sales 2027 * 5.11x
Free-Float
88.45%
Yield 2026 *
1.88%
Yield 2027 * 2.08%
1 day-0.49%
1 week-5.07%
Current month-12.07%
1 month-8.99%
3 months-4.72%
6 months-21.18%
Current year-8.38%
1 week 114.54
Extreme 114.54
122.96
1 month 114.54
Extreme 114.54
132.3
Current year 114.54
Extreme 114.54
132.49
1 year 114.54
Extreme 114.54
172.23
3 years 114.54
Extreme 114.54
201.92
5 years 114.54
Extreme 114.54
249.27
10 years 39.52
Extreme 39.5201
249.27
Manager TitleAgeSince
Chief Executive Officer 54 2019-12-31
Director of Finance/CFO 54 2021-05-31
Chief Tech/Sci/R&D Officer - 2025-12-31
Director TitleAgeSince
Director/Board Member 68 2012-06-30
Director/Board Member 68 2012-12-31
Chairman 73 2013-06-25
Change 5d. change 1-year change 3-years change Capi.($)
-0.53%-5.07%-27.98%-29.46% 48.74B
-0.04%-2.98%+119.84%+143.97% 11.28B
+7.74%+21.35%+43.68%+75.68% 6.43B
-1.05%-4.47%+9.06%+22.14% 3.23B
+0.40%+3.85%+114.18%+30.40% 2.39B
-0.16%+2.63%+140.02%+225.05% 1.99B
+2.92%+3.65%-30.72%-0.76% 1.44B
-0.05%+8.01%+13.69%-9.43% 1.3B
+0.62%+3.19%+24.50%-45.55% 1.19B
-0.25%+2.44%+6.32%-42.55% 1.08B
Average +0.95%+0.41%+41.26%+36.95% 7.91B
Weighted average by Cap. +0.35%-3.21%+10.86%+14.57%

Financials

2026 *2027 *
Net sales 9.91B 8.6B 7.77B 7.42B 13.5B 915B 13.98B 92.53B 36.74B 437B 37.2B 36.4B 1,578B 10.41B 9.03B 8.16B 7.8B 14.18B 961B 14.68B 97.17B 38.58B 459B 39.06B 38.23B 1,657B
Net income 2.87B 2.49B 2.25B 2.15B 3.91B 265B 4.05B 26.8B 10.64B 127B 10.78B 10.55B 457B 3.04B 2.64B 2.39B 2.28B 4.14B 281B 4.29B 28.39B 11.27B 134B 11.41B 11.17B 484B
Net Debt 5.18B 4.49B 4.06B 3.88B 7.06B 478B 7.3B 48.35B 19.2B 229B 19.44B 19.02B 825B 4.44B 3.85B 3.48B 3.33B 6.05B 410B 6.26B 41.45B 16.46B 196B 16.66B 16.31B 707B
Logo Zoetis Inc.
Zoetis Inc. specializes in developing, manufacturing and marketing of animal health products. Net sales break down by activity as follows: - companion animal (67.8%): cats and dogs (95.5% of net sales) and horses (4.5%); - livestock (31.3%): cattle (52.8% of sales), poultry (18.2%), swine (17.8%), fish (8.4%) and other (2.8%); - other (0.9%). Net sales break down by family of products into parasiticides (23.3%), vaccines (19.7%), dermatological products (17.9%), anti-infectives (11.9%), pain relievers (9.2%), diagnostic products (4.2%), medicated feed additives (3.2%) and other (10.6%). At the end of 2024, the group has 22 production sites worldwide. The United States accounts for 54.8% of net sales.
Employees
14,500
Date Price Change Volume
26-03-13 115.12 $ -0.29% 1,622,592
26-03-12 115.46 $ -3.61% 3,955,194
26-03-11 119.79 $ -0.58% 3,127,870
26-03-10 120.49 $ -1.53% 2,994,843
26-03-09 122.36 $ +0.77% 3,689,326
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
115.46USD
Average target price
151.00USD
Spread / Average Target
+30.78%

Quarterly revenue - Rate of surprise

SPRING SALE - 40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW